Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,364 public trials 2,842 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)

NCT04603495

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 156 locations
View Trial Details
Active, Not Recruiting

Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)

NCT06456346

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Palo Verde Cancer Specialists ( Site 0052) Glendale, Arizona, United States
  • Los Angeles Cancer Network ( Site 0025) Glendale, California, United States
  • Stanford Cancer Center ( Site 0024) Palo Alto, California, United States
  • Exempla Lutheran Medical Center ( Site 0014) Golden, Colorado, United States
View all 171 locations
View Trial Details
Active, Not Recruiting

Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease

NCT03516279

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +15 more
Locations
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
View all 291 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

NCT02598661

Conditions
Bone Marrow Diseases, Disease Attributes, Hematologic Diseases, +5 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Acrc/Arizona Clinical Research, Inc. Tucson, Arizona, United States
  • CBCC Global Research, Inc. Bakersfield, California, United States
  • UCLA Ronald Regan Medical Center Los Angeles, California, United States
View all 126 locations
View Trial Details
Active, Not Recruiting

Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia

NCT03610438

Conditions
Acute Lymphoid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Aou Ospedali Riuniti "Umberto I - G.M. Lancisi - G. Salesi"- Ancona- Sod Clinica Ematologica Ancona, Italy
  • Area Vasta N. 5 Ascoli Piceno - S. Benedetto Del Tronto, Presidio Ospedaliero Av5 Osp. Gen. Prov.Le "C.G.Mazzoni" - Uoc Ematologia Ascoli Piceno, Italy
  • Asst Papa Giovanni Xxiii - Ospedale Di Bergamo - Sc Ematologia Bergamo, Italy
  • Aou Di Bologna - Policlinico S. Orsola-Malpighi - Uoc Ematologia Bologna, Italy
View all 30 locations
View Trial Details
Active, Not Recruiting

Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia

NCT03817398

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, +12 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 173 locations
View Trial Details

Related conditions